COMPARISON OF THE EFFECTS OF PLATELET RICH FIBRIN (PRF) AND XEROFORM ON TREATMENT OF DRY SOCKET

Year 2024, Volume: 48 Issue: 2, 46 - 55, 28.08.2024

Çiğdem Karaca , Onur Koç , Nuray Er

https://izlik.org/JA35CA29WF

Abstract

Background and Aims: Dry socket is the most common
complication of dental extractions and consequence in a
remarkable reduction in quality of life. The primary objective of
this investigation is to compare the effectiveness of Platelet
Rich Fibrin (PRF) and Xeroform as remedies for dry socket.
Materials and Methods: This retrospective study utilized the
follow-up records of patients with a history of dry socket. The
first group underwent PRF treatment (n=15), while the second
group received Xeroform gauze packing for the management
of dry socket (n=16). Pain, gingival index (GI), rate of exposed
bone walls, halitosis, and dysgeusia status were assessed
preoperatively and 1 day, 3, 7, and 14 days postoperatively.
Results: Evaluations indicated that PRF outperformed
Xeroform in minimizing pain and GI scores on the 1st (P=
0.021 and 0.001, respectively) and 3rd (P=0.001 and 0.003,
respectively) postoperative days. PRF achieved statistically
greater exposed bone wall coverage than Xeroform on days
1, 3, and 7 postoperatively (P=0.000, 0.000, and 0.005,
respectively). PRF led to a significant reduction in halitosis
prevalence on the 14th day postoperatively, as compared to
the preoperative measurements (P=0.004), and on the 3rd day
postoperatively, as compared to Xeroform (P=0.029).
Conclusions: PRF may be a more suitable option for the
treatment of dry socket than Xeroform gauze packing
in patients with severe pain, excess perisocket gingival
inflammation, and halitosis.

Keywords

Alveolar Osteitis Pain , Bismuth , Dry Socket , PRF , Xeroform.

References

• 1. Koutroumpas DC, Lioumi E, Vougiouklakis G. Tooth Extraction in Antiquity. J Hist Dent 2020; 68: 127-144.
• 2. Blum IR. Contemporary views on dry socket (alveolar osteitis): a clinical appraisal of standardization, aetiopathogenesis and management: a critical review. Int J Oral Maxillofac Surg 2002; 31: 309-317.
• 3. Bui CH, Seldin EB, Dodson TB. Types, frequencies, and risk factors for complications after third molar extraction. J Oral Maxillofac Surg 2003; 61: 1379-1389.
• 4. Crawford JY. Dry sockets after extraction. Dent Cosmos 1896; 38: 929.
• 5. Cardoso CL, Rodrigues MT, Ferreira Junior O, Garlet GP, de Carvalho PS. Clinical concepts of dry socket. J Oral Maxillofac Surg 2010; 68: 1922-1932.
• 6. Kamal A, Salman B, Ar NH, Samsudin AR. Management of dry socket with low-level laser therapy. Clin Oral Investig 2021; 25: 1029-1033.
• 7. Kolokythas A, Olech E, Miloro M. Alveolar osteitis: a comprehensive review of concepts and controversies. Int J Dent 2010; 2010: 249073.
• 8. Birn H. Etiology and pathogenesis of fibrinolytic alveolitis (“dry socket”). Int J Oral Surg 1973; 2: 211-263.
• 9. Mamoun J. Dry Socket Etiology, Diagnosis, and Clinical Treatment Techniques. J Korean Assoc Oral Maxillofac Surg 2018; 44: 52-58.
• 10. Haraji A, Rakhshan V, Khamverdi N, Alishahi HK. Effects of intraalveolar placement of 0.2% chlorhexidine bioadhesive gel on dry socket incidence and postsurgical pain: a double-blind split-mouth randomized controlled clinical trial. J Orofac Pain 2013; 27: 256- 262.
• 11. Taberner-Vallverdu M, Nazir M, Sanchez-Garces MA, Gay- Escoda C. Efficacy of different methods used for dry socket management: A systematic review. Med Oral Patol Oral Cir Bucal 2015; 20: 633-639.
• 12. Choukroun J, Diss A, Simonpieri A, Girard MO, Schoeffler C, Dohan SL et al. Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part IV: clinical effects on tissue healing. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006; 101: 56-60.
• 13. Dohan DM, Choukroun J, Diss A, Dohan SL, Dohan AJ, Mouhyi J et al. Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part II: platelet-related biologic features. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006; 101: 45-50.
• 14. Chakravarthi S. Platelet rich fibrin in the management of established dry socket. J Korean Assoc Oral Maxillofac Surg 2017; 43: 160-165.
• 15. Sharma A, Aggarwal N, Rastogi S, Choudhury R, Tripathi S. Effectiveness of platelet-rich fibrin in the management of pain and delayed wound healing associated with established alveolar osteitis (dry socket). Eur J Dent 2017; 11: 508-513.
• 16. Miron RJ, Zucchelli G, Pikos MA, Salama M, Lee S, Guillemette V et al. Use of platelet-rich fibrin in regenerative dentistry: a systematic review. Clin Oral Investig 2017; 21: 1913-1927.
• 17. Lambert JR, Midolo P. The actions of bismuth in the treatment of Helicobacter pylori infection. Aliment Pharmacol Ther 1997; 11 Suppl 1: 27-33.
• 18. Barillo DJ, Barillo AR, Korn S, Lam K, Attar PS. The antimicrobial spectrum of Xeroform((R)). Burns 2017; 43: 1189-1194.
• 19. Domenico P, Baldassarri L, Schoch PE, Kaehler K, Sasatsu M, Cunha BA. Activities of bismuth thiols against staphylococci and staphylococcal biofilms. Antimicrob Agents Chemother 2001; 45: 1417-1421.
• 20. Saluja H, Dehane V, Mahindra U. Platelet-Rich fibrin: A second generation platelet concentrate and a new friend of oral and maxillofacial surgeons. Ann Maxillofac Surg 2011; 1: 53-57.
• 21. Loe H, Silness J. Periodontal Disease in Pregnancy. I. Prevalence and Severity. Acta Odontol Scand 1963; 21: 533-551.
• 22. Tas D, Kurgan S, Guney Z, Serdar MA, Tatakis DN. The effect of smoking on clinical and biochemical early healing outcomes of coronally advanced flap with connective tissue graft: Prospective cohort study. J Periodontol 2024; 95: 17-28.
• 23. Jang HJ, Choi YK, Kwon EY, Choi WH, Song JM. Is it worth applying self-irrigation after third molar extraction? A randomised controlled trial. Br J Oral Maxillofac Surg 2022; 60: 877-883.
• 24. Serdar CC, Cihan M, Yucel D, Serdar MA. Sample size, power and effect size revisited: simplified and practical approaches in pre-clinical, clinical and laboratory studies. Biochem Med (Zagreb) 2021; 31: 010502.
• 25. Eshghpour M, Dastmalchi P, Nekooei AH, Nejat A. Effect of platelet-rich fibrin on frequency of alveolar osteitis following mandibular third molar surgery: a double-blinded randomized clinical trial. J Oral Maxillofac Surg 2014; 72: 1463-1467.
• 26. La Rosa GRM, Marciano A, Priolo CY, Peditto M, Pedulla E, Bianchi A. Effectiveness of the platelet-rich fibrin in the control of pain associated with alveolar osteitis: a scoping review. Clin Oral Investig 2023.
• 27. Cieslik-Bielecka A, Dohan Ehrenfest DM, Lubkowska A, Bielecki T. Microbicidal properties of Leukocyte- and Platelet-Rich Plasma/ Fibrin (L-PRP/L-PRF): new perspectives. J Biol Regul Homeost Agents 2012; 26: 43-52.
• 28. Zhang S, Qu X, Tang H, Wang Y, Yang H, Yuan W et al. Diclofenac Resensitizes Methicillin-Resistant Staphylococcus aureus to beta- Lactams and Prevents Implant Infections. Adv Sci (Weinh) 2021; 8: 2100681.
• 29. Buonavoglia A, Trotta A, Cordisco M, Zamparini F, Corrente M, Prati C. Alveolar osteitis associated with methicillin-resistant Staphylococcus epidermidis. New Microbiol 2022; 45: 219-222.
• 30. Hickerson WL, Kealey GP, Smith DJ, Jr., Thomson PD. A prospective comparison of a new, synthetic donor site dressing versus an impregnated gauze dressing. J Burn Care Rehabil 1994; 15: 359-363.
• 31. Haith LR, Stair-Buchmann ME, Ackerman BH, Herder D, Reigart CL, Stoering M et al. Evaluation of Aquacel Ag for Autogenous Skin Donor Sites. J Burn Care Res 2015; 36: 602-606.
• 32. Lairet KF, Baer D, Leas ML, Renz EM, Cancio LC. Evaluation of an oxygen-diffusion dressing for accelerated healing of donor-site wounds. J Burn Care Res 2014; 35: 214-218.
• 33. Sordi MB, Panahipour L, Kargarpour Z, Gruber R. Platelet-Rich Fibrin Reduces IL-1beta Release from Macrophages Undergoing Pyroptosis. Int J Mol Sci 2022; 23. 55
• 34. Zhang J, Yin C, Zhao Q, Zhao Z, Wang J, Miron RJ et al. Antiinflammation effects of injectable platelet-rich fibrin via macrophages and dendritic cells. J Biomed Mater Res A 2020; 108: 61-68.
• 35. Kleinbeck KR, Faucher LD, Kao WJ. Biomaterials modulate interleukin-8 and other inflammatory proteins during reepithelialization in cutaneous partial-thickness wounds in pigs. Wound Repair Regen 2010; 18: 486-498.
• 36. Malpass KG, Snelling CF, Tron V. Comparison of donor-site healing under Xeroform and Jelonet dressings: unexpected findings. Plast Reconstr Surg 2003; 112: 430-439.
• 37. Rashed SA, Elsharkawy AT, Zaied A. Evaluation of efficacy of platelet-rich fibrin (prf) versus alvogyl and zinc oxide and eugenol (zoe) packing in the management of alveolar osteitis: A prospective randomized clinical study. Egypt Dent J 2019; 65.
• 38. Izidoro C, Botelho J, Machado V, Reis AM, Proenca L, Alves RC et al. Revisiting Standard and Novel Therapeutic Approaches in Halitosis: A Review. Int J Environ Res Public Health 2022; 19.
• 39. Feng M, Wang Y, Zhang P, Zhao Q, Yu S, Shen K et al. Antibacterial effects of platelet-rich fibrin produced by horizontal centrifugation. Int J Oral Sci 2020; 12:32.
• 40. Moraschini V, Miron RJ, Mourao C, Louro RS, Sculean A, da Fonseca LAM et al. Antimicrobial effect of platelet-rich fibrin: A systematic review of in vitro evidence-based studies Periodontol 2000. 2023.
• 41. Wu X, Ren J, Yuan Y, Luan J, Yao G, Li J. Antimicrobial properties of single-donor-derived, platelet-leukocyte fibrin for fistula occlusion: An in vitro study. Platelets 2013; 24: 632-636.